Innovative Vaccine Approaches | EK50



Sessions

INO-4800 DNA Vaccine Induces Neutralizing Antibodies and T cell Activity Against Global SARS-CoV-2 Variants

Speaker(s):

Epitope identification of SARS-CoV-2 structural proteins using in silico approaches to obtain conserved rational immunogenic peptide

Speaker(s):

BCG & Cyclic Dinucleotides join hands in fight against Tuberculosis and Viral Diseases- Novel approach towards developing a low cost PAN Corona vaccine.

Speaker(s):

First recombinant dual-hit glycoconjugate vaccine production platform to combat Group A Streptococcus

Speaker(s):

Stabilization of the SARS-CoV-2 Spike receptor-binding domain using deep mutational scanning and structure-based design

Speaker(s):

Assessing RNA recombination between an alphavirus replicon vector vaccine and wildtype alphaviruses

Speaker(s):

Sterilizing Antiviral Immunity Induced by a CD40L-Based Vaccine

Speaker(s):

Using synthetic biology to generate rapidly manufacturable hyper-stable vaccines

Speaker(s):

Vaccine nanoparticles for elicitation of strong cellular and humoral immune responses.

Speaker(s):

COVID-19 Pathogen (SARS-Cov-2) Viral Evolution Leading to Increased Infectivity

Speaker(s):
  • Sonam Parag, BS, Nova Southeastern University Dr. Kiran C. Patel College of Allopathic Medicine